脓毒症、脓毒性休克或需ICU入住患者血流感染的感染源控制:一项范围综述及标准化研究建议
该范围综述检索Medline、EMBASE和Cochrane Library,纳入77项成人血流感染研究(人群需满足ICU入住≥50%、脓毒症≥75%或脓毒性休克≥25%),评估感染源控制的定义、干预、时机、充分性和结局。感染源控制在21%的研究中为主要目标,念珠菌血症(47%)和导管移除(60%)研究占主导,34%的研究不论血流感染来源均评估导管移除。感染源控制定义从无定义(8%)、最低限度(7%)、简明(17%)、全面(9%)到导管移除(60%)不等。47%的研究报告整个队列接受感染源控制的比例而非需要感染源控制者的比例。68%报告时机但定义不一致,仅3%评估充分性。65%的研究显示感染源控制改善结局,未报告伤害。作者认为标准化报告对提升证据质量和优化重症患者血流感染管理至关重要。
要点
- 感染源控制在65%的纳入研究中改善结局,未报告伤害,但研究间定义和评估方法高度异质。
- 60%的研究以导管移除作为感染源控制定义,34%的研究不论血流感染来源均评估导管移除,过度代表导管相关血流感染。
- 47%的研究报告整个队列接受感染源控制的比例,而非仅报告需要感染源控制者的比例,可能低估实际实施率。
- 68%的研究报告感染源控制时机但定义不一致,仅3%评估感染源控制充分性。
- 念珠菌血症(47%)和导管移除(60%)研究占主导,其他感染源类型的感染源控制研究不足。
适用人群与场景
- 成人血流感染患者,研究人群需满足ICU入住≥50%、脓毒症≥75%或脓毒性休克≥25%。
研究设计与关键结果
- 范围综述,检索Medline、EMBASE和Cochrane Library,从2193篇摘要中纳入77项研究。
- 感染源控制在21%的研究中为主要目标,其余研究与其他目标一并报告。
- 念珠菌血症研究占47%,导管移除研究占60%,34%的研究不论血流感染来源均评估导管移除。
- 感染源控制定义:无定义8%、最低限度7%、简明17%、全面9%、导管移除60%。
- 47%的研究报告整个队列接受感染源控制的比例而非需要感染源控制者的比例;68%报告时机但定义不一致;3%评估充分性。
- 65%的研究显示感染源控制改善结局,未报告伤害。
证据类型、等级与局限
- 证据类型:范围综述。
- 局限:感染源控制定义不一致、感染源控制疗效评估不足、过度代表导管源性血流感染和念珠菌血症。
对床旁实践的改变
- 作者认为标准化报告对提升证据质量和优化重症患者血流感染管理至关重要。
- 当前证据不足以支持对非导管源性或非念珠菌性血流感染的感染源控制制定统一推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Bloodstream infections (BSI) account for 15% of intensive care unit (ICU) infections, often causing sepsis with mortality rates up to 50%. Source control (SC), encompassing interventions to reduce bacterial or fungal load and prevent infection spread, is a critical yet under-investigated component of management.
OBJECTIVES: This scoping review examines SC definitions, interventions, timing, adequacy, and outcomes in BSI literature in patients with sepsis, septic shock, or ICU admission, and offers a proposal for standardized reporting.
METHODS: We searched Medline, EMBASE, and Cochrane Library for studies on adult BSI addressing SC in populations with ≥ 50% ICU admission, ≥ 75% sepsis, or ≥ 25% septic shock, extracted and reported data following established guidance.
RESULTS: From 2193 abstracts, 77 studies were included. SC was a primary objective in 21%, with others reporting it alongside other objectives. Candidemia (47%) and catheter removal (60%) studies were predominant, with 34% evaluating catheter removal regardless of BSI source. SC definitions varied from no definition (8%), minimal (7%), concise (17%), comprehensive (9%) definitions and catheter removal (60%). Forty-seven % reported proportions receiving SC for the entire cohort rather than those requiring SC. Timing was reported by 68%, with inconsistent definitions. SC adequacy was assessed by 3%. SC improved outcomes in 65%, with no reported harm.
CONCLUSION: SC research in severe BSI is limited by inconsistent definitions, poor SC efficacy assessments, and overrepresentation of catheter-source BSI and candidemia. Standardized reporting is essential to enhance evidence quality and optimize BSI management in critically ill patients.
参考来源
- Tabah A, De Waele J, Ssi Yan Kai N, et al. Source control in bloodstream infections in patients with sepsis, septic shock, or requiring ICU admission: a scoping review with recommendations for standardizing research. Intensive Care Med. 2025. PMID: 40658248. doi:10.1007/s00134-025-08026-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。